Lung inflammation and pulmonary function in infants with meconium aspiration syndrome

Pediatric Pulmonology

Volumn 42, Issue 10, 2007, Pages 898-905

  Cayabyab, Rowena G ^a,b   Kwong, Kenny ^a   Jones, Craig ^a   Minoo, Parviz ^a   Durand, Manuel ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WOMEN S AND CHILDREN S HOSPITAL   (United States)

Author keywords

Cell count; Cytokines (IL 1 ; IL 6; IL 8; TNF ); Inflammation; Meconium aspiration syndrome; Oxygenation index; Pulmonary function

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY PRESSURE; ARTERIAL OXYGEN TENSION; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GESTATIONAL AGE; HUMAN; INFANT; INFLAMMATORY INFILTRATE; LUNG ALVEOLUS OXYGEN TENSION; LUNG COMPLIANCE; LUNG FUNCTION; MECONIUM ASPIRATION; PNEUMONIA; PRIORITY JOURNAL; PULMONOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIDAL VOLUME;

CYTOKINES; HUMANS; INFANT, NEWBORN; INFLAMMATION; LUNG; LYMPHOCYTE COUNT; MECONIUM ASPIRATION SYNDROME; RESPIRATION; RESPIRATORY FUNCTION TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRACHEA;

EID: 35148883688     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20675     Document Type: Article

References (34)

1. Paranka MS, Clark RH, Yoder BA, Null DM Jr. Predictors of failure of high-frequency oscillatory ventilation in term infants with severe respiratory failure. Pediatrics 1995;95:400-404.
2. The Neonatal Inhaled Nitric Oxide Study Group, Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
3. Findlay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 1996;97:48-52.
4. Dargaville PA, Copnell B. The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome. Pediatrics 2006;117:1712-1721. for the Australian and New Zealand Neonatal Network.
5. Davis PJ, Shekerdemian LS. Meconium aspiration syndrome and extracorporeal membrane oxygenation. Arch Dis Child Fetal Neonatal Ed 2001;84:F1-F3.
6. Cleary GM, Wiswell TE. Meconium stained amniotic fluid and the meconium aspiration syndrome: an update. Pediatr Clin North Am 1998;45:511-529.
7. Tyler D, Murphy J, Cheney F. Mechanical and chemical damage to lung tissue caused by meconium aspiration. Pediatrics 1978;62:454-459.
8. Davey AM, Becker JD, Davis JM. Meconium aspiration syndrome: physiological and inflammatory changes in a newborn piglet model. Pediatr Pulmonol 1993;16:101-108.
9. Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr 1998;132:40-47.
10. Yen TF, Lilien LD, Barathi A, Pildes RS. Lung volume, dynamic lung compliance, and blood gases during the first 3 days of postnatal life in infants with meconium aspiration syndrome. Crit Care Med 1982;10:588-592.
11. Moses D, Holm BA, Spitale P, Liu M, Enhorning G. Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol 1991;164:477-481.
12. Jones CA, Cayabyab RG, Kwong KYC, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA. Undetectable IL-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996;39:966-975.
13. Zagariya A, Bhat R, Uhal B, Navale S, Freidine M, Vidyasagar D. Cell death and lung histology in meconium aspirated newborn rabbit lung. Eur J Pediatr 2000;159:819-826.
14. de Beaufort AJ, Pelikan DMV, Elferink JGR, Berger HM. Effect of interleukin 8 in meconium on in vitro neutrophil Chemotaxis. Lancet 1998;352:102-105.
15. de Beaufort AJ, Bakker AC, van Tol MJD, Poorthuis BJ, Schrama AJ, Berger HM. Meconium is a source of proinflammatory substances and can induce cytokine production in cultured A549 epithelial cells. Pediatr Res 2003;54:491-495.
16. Castellheim A, Pharo A, Fung M, Saugstad OD, Mollnes TE. Complement C5a is a key mediator of meconium-induced neutrophil activation. Pediatr Res 2005;57:242-247.
17. Mokry J, Mokra D, Antosova M, Bulikova J, Calkovska A, Nosalova G. Dexamethasone alleviates meconium-induced airway hyperresponsiveness and lung inflammation in rabbits. Pediatr Pulmonol 2006;41:55-60.
18. Kwong KYC, Jones CA, Cayabyab RG, Lecart C, Stotts C, Randhawa I, Ramanathan R, Khuu N, Minoo P, deLemos RA. Differential regulation of IL-8 by IL-1β and TNF-α in hyaline membrane disease. J Clin Immunol 1998;18:71-80.
19. Kwong KYC, Jones CA, Cayabyab RG, Lecart C, Khuu N, Randhawa I, Hanley JM, Ramanathan R, deLemos RA, Minoo P. The effects of IL-10 on proinflammatory cytokine expression (IL-1β and IL-8) in hyaline membrane disease (HMD). Clin Immunol Immunopath 1998;88:105-113.
20. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ. Increase in interleukin (IL)-1β and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996;40:250-256.
21. Groneck P, Speer CP. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 1995;73:F1-F3.
22. Durand M, Mendoza ME, Tantivit P, Kugelman A, McEvoy C. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation. Pediatrics 2002;109:262-268.
23. Goldman SL, Bosque E, McCann E, Lewis K. Pulmonary mechanics in premature infants one month after treatment with synthetic surfactant. J Pediatr 1992;120:S25-S28.
24. McEvoy C, Sardesai S, Macri C, Paul R, Durand M. Neonatal pulmonary mechanics and oxygenation after prophylactic amnioinfusion in labor: a randomized clinical trial. Pediatrics 1995;95:688-692.
25. Marsh TD, Wilkerson SA, Cook LN. Extracorporeal membrane oxygenation selection criteria: partial pressure of arterial oxygen versus alveolar-arterial oxygen gradient. Pediatrics 1988;82:162-166.
26. Durand M, Snyder JR, Gangitano E, Wu PYK. Oxygenation index in patients with meconium aspiration: conventional and extracorporeal membrane oxygenation therapy. Crit Care Med 1990;18:373-377.
27. 2 after exposure of human airway epithelial cells to meconium. Pediatr Pulmonol 2002;33:111-116.
28. Kojima T, Hattori K, Fujiwara T, Sasai-Takedatsu M, Kobayashi Y. Meconium induced lung injury mediated by activation of alveolar macrophage. Life Sci 1994;21:1559-1562.
29. Holopainen R, Aho H, Laine J, Peuravuori H, Soukka H, Kaapa P. Human meconium has high phospholipase activity and induces cellular injury and apoptosis in piglet lungs. Pediatr Res 1999;46:626-638.
30. Dargaville PA, South M, McDougall PN, Surfactant and, surfactant inhibitors in meconium aspiration syndrome. J Pediatr 2001;138:113-115.
31. Lotze A, Short BL, Taylor GA. Lung compliance as a measure of lung function in newborns with respiratory failure requiring extracorporeal membrane oxygenation. Crit Care Med 1987;15:226-229.
32. Kugelman A, Gangitano E, Taschuk R, Garza R, Riskin A, McEvoy C, Durand M. Extracorporeal membrane oxygenation in infants with meconium aspiration syndrome: a decade of experience with venovenous ECMO. J Pediatr Surg 2005;40:1082-1089.
33. ERS Task Force on Bronchoalveolar Lavage in Children Bronchoalveolar lavage in children. Eur Respir J 2000;15:217-231.
34. Dargaville PA, South M, Vervaart P, McDougall PN. Validity of markers of dilution in small volume lung lavage. Am J Respir Crit Care Med 1999;160:778-784.